These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19917383)

  • 1. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live donor liver transplantation in high MELD score recipients.
    Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
    Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for end-stage liver disease can predict very early outcome after liver transplantation.
    Briceño J; Sánchez-Hidalgo JM; Naranjo A; Ciria R; Pozo JC; Luque A; de la Mata M; Rufián S; López-Cillero P
    Transplant Proc; 2008 Nov; 40(9):2952-4. PubMed ID: 19010157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation.
    Akyildiz M; Karasu Z; Arikan C; Kilic M; Zeytunlu M; Gunsar F; Ersoz G; Akarca U; Batur Y; Tokat Y
    Transplant Proc; 2004 Jun; 36(5):1442-4. PubMed ID: 15251354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MELD and prediction of post-liver transplantation survival.
    Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO
    Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
    Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
    Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
    Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant.
    Bazarah SM; Peltekian KM; McAlister VC; Bitter-Suermann H; MacDonald AS
    Clin Invest Med; 2004 Aug; 27(4):162-7. PubMed ID: 15453152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL; Martín LG; Martín EE; Pajares Ad; Pérez AM; Seral CC; Marugán RB
    Transplant Proc; 2005 Nov; 37(9):3881-3. PubMed ID: 16386571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher graft-to-host ratio may decrease posttransplant mortality in patients with a high MELD score.
    Emiroglu R; Yilmaz U; Coskun M; Karakayali H; Haberal M
    Transplant Proc; 2007 May; 39(4):1164-5. PubMed ID: 17524921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
    Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR; Pokorny H; Hetz H; Herkner H; Rasoul-Rockenschaub S; Soliman T; Wekerle T; Berlakovich GA; Steininger R; Muehlbacher F
    Transplantation; 2007 Mar; 83(5):588-92. PubMed ID: 17353779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.